Product Highlight - Apidra Solostar

17 Aug 2022
Product Highlight - Apidra Solostar

                                                                                    The Ideal Partner for Basal Insulin1
                                                                          Now available at an even more affordable price!2

  •  An antidiabetic agent used to reduce high blood sugar in patients with diabetes mellitus; it may be given to adults, adolescents and children, 6 years of age and older. It has a rapid onset within 10-20 minutes and a short duration, about 4 hours.3
  •  Significantly reduces HbA1c when added with basal insulin for FPG and PPG control1 Superior efficacy of insulin glargine + pre-meal insulin glulisine (basal-bolus) vs. premixed insulins4
  •  Lesser hypoglycemic events with basal-bolus vs. premixed insulins4
  •  Insulin Glulisine 100 units/mL (Apidra Solostar®) – New SRP Php 435.00 per pen (Savings of Php 383.75 from previous SRP)2

 

 
REFERENCES:
(1) MR Lankisch et.al. Diabetes, Obesity and Metabolism, 2008: 10:1178-1186
(2) Based from MDC prices as of June 2,2020
(3) Apidra Prescribing Info 2008
(4) Fritsche M. et.al. Diabetes, Obesity and Metabolism, 2010: 12:115-123
This material is strictly for HCPs only.

MAT-PH-2000194 / Ver 1.0 / DA 07-2020 / DM 07-2020


sanofi-aventis PHILS. INC.
21st to 23rd Flr. One World Place Corporate Offices. 32nd St.
Bonifacio Global City, Taguig City 1634, Metro Manila.
Website: www.sanofi.ph

Related MIMS Drugs